Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,765,909
-
Share change
-
-151,151
-
Total reported value
-
$1,949,890,985
-
Put/Call ratio
-
46%
-
Price per share
-
$85.65
-
Number of holders
-
201
-
Value change
-
-$18,461,450
-
Number of buys
-
113
-
Number of sells
-
103
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2015
As of 30 Sep 2015,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,765,909 shares.
The largest 10 holders included
RS INVESTMENT MANAGEMENT CO LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Knott David M, FMR LLC, OAK RIDGE INVESTMENTS LLC, Invesco Ltd., CARDINAL CAPITAL MANAGEMENT LLC /CT, and Bank of New York Mellon Corp.
This page lists
201
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.